Canine Arthritis Treatment Market Trends and Growth Opportunities Through 2026–2030

April 8, 2026April 8, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Market Size Of The Allergic Rhinitis Drugs Market In 2026 And What Value Is Projected For 2030?

The canine arthritis treatment market size has experienced significant growth over recent years. This market is projected to expand from $2.47 billion in 2025 to $2.6 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 5.4%. Historically, this expansion has been driven by factors including the increasing prevalence of canine arthritis, enhanced awareness among pet owners, progress in veterinary pharmaceuticals, an expanding dog population, and the proliferation of veterinary clinics and hospitals.

The market for canine arthritis treatment is projected to experience consistent expansion over the upcoming years. It is anticipated to reach $3.13 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 4.7%. This expansion during the projection period stems from factors such as the advancement of targeted biologic treatments, the wider adoption of precision medicine in veterinary practices, breakthroughs in surgical methods for joint repair, the proliferation of online and physical veterinary pharmacies, and increased funding for stem cell and PRP research. Key developments anticipated in this period encompass the growing preference for non-steroidal anti-inflammatory drugs (NSAIDs), a rise in the application of joint supplements like glucosamine and chondroitin, an increase in stem cell therapy and platelet-rich plasma (PRP) interventions, the wider availability of minimally invasive surgical procedures for dogs, and the incorporation of physical therapy and cold laser therapy into arthritis management protocols.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16007&type=smp

What Major Drivers Are Influencing Demand In The Allergic Rhinitis Drugs Market?

The anticipated expansion of the **canine arthritis treatment market** going forward is significantly propelled by the increasing rate of pet ownership. Pet ownership involves the responsibility and care individuals or households provide for the needs, well-being, and companionship of domesticated animals kept primarily for pleasure rather than utility. This surge in pet ownership is attributed to evolving lifestyle changes, the humanization of pets, and higher disposable incomes. Pet owners employ **canine arthritis treatments** to manage and alleviate the symptoms of arthritis in their dogs, with the goal of improving their pets’ quality of life and sustaining mobility. For instance, in **April 2025**, data from the **Canadian Animal Health Institute**, a **Canada**-based trade association, revealed that in **2024**, **Canada** housed an estimated **7.2 million dogs** and **8.2 million cats**, signifying that pets are a vital component of more than **half of Canadian households**. Hence, the escalating pet ownership rate is a primary driver for the growth of the **canine arthritis treatment market**.

What Are The Key Segments Of The Allergic Rhinitis Drugs Market?

The canine arthritis treatment market covered in this report is segmented –

1) By Treatment Type: Drugs, Supplements, Surgical Procedures, Other Treatment Types

2) By Route Of Administration: Oral, Parenteral, Other Routes Of Administrations

3) By Arthritis Type: Osteoarthritis, Rheumatoid Arthritis, Osteochondrosis, Traumatic Arthritis

4) By Distribution Channels: Veterinary Clinics And Hospitals, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Drugs: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Disease-Modifying Osteoarthritis Drugs (DMOADs), Corticosteroids, Analgesics And Pain Relievers

2) By Supplements: Glucosamine And Chondroitin Supplements, Omega-3 Fatty Acids And Fish Oil, Hyaluronic Acid Supplements, MSM (Methylsulfonylmethane) Supplements, Collagen-Based Supplements

3) By Surgical Procedures: Joint Replacement Surgery, Arthroscopy, Osteotomy, Synovectomy

4) By Other Treatment Types: Physical Therapy, Stem Cell Therapy, Platelet-Rich Plasma (PRP) Therapy, Cold Laser Therapy (Low-Level Laser Therapy), Acupuncture

What Key Trends Are Influencing The Development Of The Canine Arthritis Treatment Market?

Leading companies in the canine arthritis treatment market are developing innovative therapies, such as bedinvetmab injections, to address canine joint health and mobility. Bedinvetmab is a monoclonal antibody injection that functions by targeting and neutralizing nerve growth factor (NGF), a protein linked to pain in veterinary medicine. For instance, in May 2023, Zoetis Inc., a US-based animal health company, received approval from the Food and Drug Administration (FDA) for Librela, a bedinvetmab injection. This marks the first monoclonal antibody (mAb) approved by the FDA for canine use, working by binding to and inhibiting the biological activity of canine nerve growth factor (NGF), which plays a role in regulating pain associated with OA. Administered via subcutaneous injection once a month, it offers a convenient and long-term solution for managing canine OA pain.

Who Are The Leading Companies Operating In The Allergic Rhinitis Drugs Market?

Major companies operating in the canine arthritis treatment market are Merck & Co. Inc., Bayer AG, Eli Lilly and Company, Zoetis Inc., Boehringer Ingelheim Animal Health, Elanco Animal Health Incorporated, Royal Canin SAS, Virbac Group, Ceva Sante Animale S.A., Hill’s Pet Nutrition Inc., Vetoquinol SA, Norbrook Laboratories Limited, American Regent Inc., Thorne Healthtech Inc., VetStem Inc., Eltech K-Laser s.r.l., Liquid Health Inc, Nutri-Vet LLC, OrthoPets LLC, Rejuvenate Bio Inc.

Read the full canine arthritis treatment market report here:

https://www.thebusinessresearchcompany.com/report/canine-arthritis-treatment-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Allergic Rhinitis Drugs Market?

North America was the largest region in the canine arthritis treatment market in 2025. Asia-Pacifica is expected to be the fastest-growing region in the forecast period. The regions covered in the canine arthritis treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Allergic Rhinitis Drugs Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=16007&type=smp

Browse Through More Reports Similar to the Global Canine Arthritis Treatment Market 2026, By The Business Research Company

Companion Animal Arthritis Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/companion-animal-arthritis-global-market-report

Veterinary Orthopedic Medicine Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-orthopedic-medicine-global-market-report

Veterinary Pain Management Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-pain-management-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795